Literature DB >> 23987986

Effect of a GnRH analogue (Maprelin) on the reproductive performance of gilts and sows.

Ellen de Jong1, Johannes Kauffold, Silke Engl, Jan Jourquin, Dominiek Maes.   

Abstract

The ability of peforelin (l-GnRH-III) to stimulate follicular growth, FSH release, and estrus in gilts after altrenogest treatment and in sows after weaning was investigated. In three farrow-to-wean herds, with at least 600 sows and average production performance, 216 gilts, 335 primiparous, and 1299 pluriparous sows were randomly allocated to three treatments: peforelin (M group: Maprelin), eCG (F group: Folligon), and physiological saline solution (C group). Animals were treated 48 hours after their last altrenogest treatment (gilts) or 24 hours after weaning (sows). The weaning-to-estrus interval, estrus duration, estrus rate (ER), pregnancy rate, and total born (TB), live born, and stillborn (SB) numbers were recorded and compared between treatments for the different parity groups (gilts and primiparous and pluriparous sows). Follicle sizes were measured in representative animals from each group on the occasion of their last altrenogest treatment or at weaning, and also on the occasions of their first (FS1) and second (FS2) attempted inseminations. Blood samples were taken to determine FSH concentrations at weaning and 2 hours after injection, and progesterone concentrations 10 days after the first insemination attempt. The relative change in FSH concentrations was calculated. Significant differences were found for ER within 7 days of weaning in pluriparous sows (95%, 91%, and 90% for the M, F, and C groups, respectively, P = 0.005). Gilts in the F-group had high TB numbers, and pluriparous sows in the M group had high SB numbers (TB gilts = 13.6, 15.4, and 14.9 [P = 0.02] and SB pluriparous sows = 1.8, 1.4, and 1.7 [P = 0.05] for the M, F, and C groups, respectively). The M group had the highest FS1 (for gilts) and FS2 (for pluriparous sows) values: FS1 = 5.4, 4.9, and 4.9 mm [P = 0.02] and FS2 = 6.8, 5.3, and 6.3 mm [P = 0.03] for the M, F, and C groups, respectively. There were no significant differences between the different treatments within each parity group with respect to any of the other variables. Overall, peforelin treatment had small but positive effects on the ER and follicle growth in certain parity groups but did not seem to affect litter sizes or FSH and progesterone levels in sows on the occasions of the corresponding examinations.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Estrus; Gonadotropins; Peforelin; Sows

Mesh:

Substances:

Year:  2013        PMID: 23987986     DOI: 10.1016/j.theriogenology.2013.07.012

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  An evaluation of gonadotropin-releasing hormone analogue administered to gilts and sows on subsequent reproductive performance and piglet birth weight.

Authors:  Frédéric Vangroenweghe; Lieve Goossens; Jan Jourquin
Journal:  Porcine Health Manag       Date:  2016-01-11

2.  Effect of a GnRH analogue (peforelin) on the litter performance of gilts and sows.

Authors:  Ellen de Jong; Jan Jourquin; Johannes Kauffold; Steven Sarrazin; Jeroen Dewulf; Dominiek Maes
Journal:  Porcine Health Manag       Date:  2017-03-15

3.  The effect of fixed-time artificial insemination protocol initiated at different stages of the estrous cycle on follicle development and ovulation in gilts.

Authors:  Xiaoyu Chen; Fuxian Yu; Zhiwei Zhu; Jing Huang; Liang Zhang; Jianzhi Pan
Journal:  J Reprod Dev       Date:  2021-10-16       Impact factor: 2.214

4.  Single Fixed-Time Post-Cervical Insemination in Gilts with Buserelin.

Authors:  Andrés Suárez-Usbeck; Olga Mitjana; María Teresa Tejedor; Cristina Bonastre; Jorge Sistac; Antonio Ubiergo; María Victoria Falceto
Journal:  Animals (Basel)       Date:  2021-05-27       Impact factor: 2.752

Review 5.  Recent advancements in the hormonal stimulation of ovulation in swine.

Authors:  Robert V Knox
Journal:  Vet Med (Auckl)       Date:  2015-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.